$0.17
-0.01 (-5.67%)
Open$0.17
Previous Close$0.18
Day High$0.18
Day Low$0.15
52W High$13.80
52W Low$0.18
Volume—
Avg Volume1.71M
Market Cap7.50M
P/E Ratio—
EPS$-9.85
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.42M | 3.23M | 3.00M |
| Net Income | -386,907 | -351,594 | -373,147 |
| Profit Margin | -11.3% | -10.9% | -12.5% |
| EBITDA | -622,705 | -634,407 | -526,103 |
| Free Cash Flow | -366,603 | -274,517 | -229,625 |
| Rev Growth | +21.7% | +15.6% | +5.5% |
| Debt/Equity | 0.38 | 0.31 | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |